| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/19/2009 | CN100528193C A method for preparing houttuynia honeysuckle flower injection and product obtained thereby |
| 08/19/2009 | CN100528185C Chinese medicine capsule for treating AIDS and its preparing method |
| 08/19/2009 | CN100528183C Capsule for treating gout |
| 08/19/2009 | CN100528181C Medicine composition for treating kidney-yang deficiency and sexual function decrement, and its prepairng method |
| 08/19/2009 | CN100528177C Red yeast preparation containing active components of glossy ganoderma and its preparation process |
| 08/19/2009 | CN100528176C Chinese traditional medicinal composition for treating acne |
| 08/19/2009 | CN100528175C Deporteinnized calf serum injection and its preparing method |
| 08/19/2009 | CN100528174C Combination of cytidine disodium triphosphate and arginine, and preparation method thereof |
| 08/19/2009 | CN100528171C Oil-in-water baicalin nano-milk oral liquid and its preparing process |
| 08/19/2009 | CN100528170C Mangiferin preparation and production thereof |
| 08/19/2009 | CN100528165C Stable medicine composition of setastine or its salt |
| 08/19/2009 | CN100528163C Oral cavity disintegration tablet for treating gout and its preparation method |
| 08/19/2009 | CN100528162C Pharmaceutical compositions |
| 08/19/2009 | CN100528161C Medicinal composition |
| 08/19/2009 | CN100528160C An antibacterial rifampicin nanoemulsion and preparation method thereof |
| 08/19/2009 | CN100528158C Pharmaceutical composition for oral administration of a pyrazol-3-carboxamide derivative |
| 08/19/2009 | CN100528157C Form of presentation for 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester to be administered oral |
| 08/19/2009 | CN100528155C Nanometer berberine hydrochloride emulsion and its preparation process |
| 08/19/2009 | CN100528153C Percutaneous absorption type cerebral protective agent |
| 08/19/2009 | CN100528151C Pharmaceutical formulations of modafinil |
| 08/19/2009 | CN100528150C Novel pharmaceutical formulations of modafinil |
| 08/19/2009 | CN100528148C Oil-in-water type nanometer peonol emulsion oral liquid and its preparation process |
| 08/19/2009 | CN100528147C Method for preparing protein-polysaccharide vitreum slow release microsphere by using low-temperature aqueous-aqueous phase emulsion |
| 08/19/2009 | CN100528146C Therapeutic system for the controlled release of active ingredients |
| 08/19/2009 | CN100528145C Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form |
| 08/19/2009 | CN100528144C Aceclofenac in extended-released tablets and method of manufacturing the same |
| 08/19/2009 | CN100528143C Method of preparing concentrated pill of six ingredients with rehmannia |
| 08/19/2009 | CN100528142C Aidi drops for treating cancers and preparation thereof |
| 08/19/2009 | CN100528141C Freeze dried ligustrazine hydrochloride preparation for injection and its preparation process |
| 08/19/2009 | CN100528140C Stable shaped particles of crystalline organic compounds and preparation method thereof |
| 08/19/2009 | CN100528139C Preserved ophthalmic compositions |
| 08/18/2009 | US7576255 Silver-containing compositions, devices, and methods for making |
| 08/18/2009 | US7576181 Method of administering porcine B-domainless fVIII |
| 08/18/2009 | US7576133 Stimulants; narcolepsy therapy |
| 08/18/2009 | US7576067 Pulsatile release compositions and methods for enhanced intestinal oligonucleotide drug absorption |
| 08/18/2009 | US7576066 Administering nucleic acid to stimunlate immunology response |
| 08/18/2009 | US7576055 Comprised of three lipid elements: phosphatidyl choline, fatty-acyl-cholesterol esters, and at least one apolipoprotein; brain disorders; kits; efficiently target and deliver substances |
| 08/18/2009 | US7575904 Polymer grafting by polysaccharide synthases |
| 08/18/2009 | US7575763 Membrane scaffold proteins and tethered membrane proteins |
| 08/18/2009 | US7575762 Composition comprises sustained-release fine particles and manufacturing method thereof |
| 08/18/2009 | US7575761 A pharmaceutical formulation system for producing dry powders comprising an atomizer, conditioning zones coupled to the atomizer and dryer; pulmonary drug delivery |
| 08/18/2009 | US7575760 Vitamin tablet enhancing appetite and calcium absorption; comprising a vitamin, lysine or a pharmaceutically acceptable salt thereof, a sweetener, and a pharmaceutically or dietetically acceptable carrier |
| 08/18/2009 | US7575757 Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof |
| 08/18/2009 | US7575743 Removing a portion of synovial membrane tissue from the animal; and filling the cartilage defect with the synovial membrane tissue. |
| 08/18/2009 | US7575739 Foamable iodine composition |
| 08/18/2009 | US7575574 Apparatus for piezoelectric layer-wise pump and valve for use in local administration of biological response modifiers and therapeutic agents |
| 08/18/2009 | CA2548739C Uv-stable, liquid or semisolid transdermal administration form comprising a photosensitive active ingredient |
| 08/18/2009 | CA2463172C Polymeric micelle composition with improved stability |
| 08/18/2009 | CA2459312C Infusion device and driving mechanism for same |
| 08/18/2009 | CA2429270C Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition |
| 08/18/2009 | CA2424554C Antacid and laxative tablet |
| 08/18/2009 | CA2416383C Solution-, dispersion- or emulsion-producing film dermatics |
| 08/18/2009 | CA2401569C Low dose entecavir formulation and use |
| 08/18/2009 | CA2392284C Medical device |
| 08/18/2009 | CA2388731C Pharmaceutical products and methods of fabrication therefor |
| 08/18/2009 | CA2369444C Pharmaceutical compositions of erythropoietin |
| 08/18/2009 | CA2353835C Composition set and kit for use in intraocular surgery |
| 08/18/2009 | CA2335250C Temperature-sensitive liposomal formulation |
| 08/18/2009 | CA2333004C Formoterol polymorphs |
| 08/18/2009 | CA2315141C Pharmaceutical compositions comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof |
| 08/18/2009 | CA2226425C Drug delivery compositions for improved stability of steroids |
| 08/18/2009 | CA2224150C Use of locally applied dna fragments |
| 08/18/2009 | CA2184841C Recombinant adenovirus coding for glial-derived neurotrophic factor (gdnf) |
| 08/13/2009 | WO2009100446A1 Compositions for delivery of cargo such as drugs proteins and/or genetic materials |
| 08/13/2009 | WO2009100441A2 Depot formulations |
| 08/13/2009 | WO2009100435A2 Sclerotherapy for varicose veins |
| 08/13/2009 | WO2009100422A2 Drug delivery system comprising microparticles and gelation system |
| 08/13/2009 | WO2009100367A2 Compositions comprising topical dpd inhibitors and methods of using same in the treatment of hand-foot syndrome |
| 08/13/2009 | WO2009100348A2 Peptides and peptide mimetics to treat pathologies associated with eye disease |
| 08/13/2009 | WO2009100330A2 Platinum aggregates and process for producing the same |
| 08/13/2009 | WO2009100272A2 Effervescent compositions |
| 08/13/2009 | WO2009100245A1 Low dose hmg-coa reductase inhibitor with reduced side effects |
| 08/13/2009 | WO2009100219A1 Spraying device and related method for cell aggregates and cell aggregate suspension thereof |
| 08/13/2009 | WO2009100216A1 Composition for sustained release delivery of proteins or peptides |
| 08/13/2009 | WO2009100176A2 Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
| 08/13/2009 | WO2009100137A2 Magnetic cells for localizing delivery and tissue repair |
| 08/13/2009 | WO2009100107A2 Alendronate formulations, method of making and method of use thereof |
| 08/13/2009 | WO2009099959A2 Tumor cell expression of neuropilin as a target for cancer therapy |
| 08/13/2009 | WO2009099831A2 Edible film-strips with modified release active ingredients |
| 08/13/2009 | WO2009099830A2 Edible film-strips for immediate release of active ingredients |
| 08/13/2009 | WO2009099734A1 Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor |
| 08/13/2009 | WO2009099650A2 Treatment of bladder diseases with a tlr7 activator |
| 08/13/2009 | WO2009099641A2 Stabilized protein compositions |
| 08/13/2009 | WO2009099467A2 Cyclosporin compositions |
| 08/13/2009 | WO2009099392A1 Compositions of phytosterols with enhanced bioavailability |
| 08/13/2009 | WO2009099132A1 Method for improving storage stability of glutathione |
| 08/13/2009 | WO2009099120A1 Aqueous dispersion containing polysaccharide particulate gel and method for producing the same |
| 08/13/2009 | WO2009098697A1 Modafinil and sildenafil dosage forms |
| 08/13/2009 | WO2009098663A1 Pharmaceutical compositions of entacapone co-micronized with sugar alcohols |
| 08/13/2009 | WO2009098661A1 Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability |
| 08/13/2009 | WO2009098531A1 Dental composition for desensitization and disinfection of exposed dentin |
| 08/13/2009 | WO2009098520A2 Composition and method for assisting swallowing |
| 08/13/2009 | WO2009098476A1 Topical antimicrobial compositions |
| 08/13/2009 | WO2009098404A2 Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof |
| 08/13/2009 | WO2009098318A1 Liquid formulation of fsh |
| 08/13/2009 | WO2009098195A1 Oral pharmaceutical formulations containing gliclazide |
| 08/13/2009 | WO2009098169A1 Orally disintegrating tablets with speckled appearance |
| 08/13/2009 | WO2009097691A1 USE OF P27kip1 FOR THE PREVENTION AND TREATMENT OF HEART FAILURE |
| 08/13/2009 | WO2009097672A2 Pharmaceutical composition, dressing and method for treating skin lesion, intermediate composition and process for preparing said dressing, and use of cerium salt associated with a collagen matrix |
| 08/13/2009 | WO2009077732A3 Slow release compositions |